SciELO - Scientific Electronic Library Online

 
vol.57 issue2Hematopoietic stem cell transplantation in the myelodisplastic syndromesHematopoietic stem-cell transplantation in aplastic anemia author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de investigación clínica

On-line version ISSN 2564-8896Print version ISSN 0034-8376

Abstract

GOMEZ-ALMAGUER, David; RUIZ-ARGUELLES, Guillermo J.; GUTIERREZ-AGUIRRE, César H.  and  JAIME-PEREZ, José C.. Non-myeloablative transplant of hematopoyetic precursor cells: Myth and reality. Rev. invest. clín. [online]. 2005, vol.57, n.2, pp.291-297. ISSN 2564-8896.

The feasibility of applying allogeneic cell -mediated therapy in conjunction with allogeneic hematopoietic cell transplantation following reduced -intensity conditioning, with minimal toxicity and no serious transplant-related complications, makes it possible to perform such procedures on an outpatient basis as well to offer a valid option for cure to elderly individuals and patients with less than optimal performance status. Based on available experience, clinical application of this innovative therapy may open new horizons for the treatment of patients with leukemia, lymphoma, myeloma and other diseases. Many patients can now benefit from the advantages of immunotherapy mediated by alloreactive donor lymphocytes, while minimizing transplant-related toxicity and mortality. This kind of transplant is making real progress in the world of transplantation.

Keywords : Allogeneic; Reduced-intensity; Conditioning hematopoietic cell.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License